Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-034853
Filing Date
2020-12-22
Accepted
2020-12-22 17:30:10
Documents
1
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5225
  Complete submission text file 0000899243-20-034853.txt   7669
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101
Business Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101 206-441-5064
Alpine ImmunoSciences, L.P. (Reporting) CIK: 0001628571 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 201409061

Mailing Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101
Business Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101 206-441-5064
Alpine Bioventures, GP, LLC (Reporting) CIK: 0001712676 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 201409062